News: N4 Pharma announces collaboration with SRI to target and treat cells in the human body that have been previously unreachable
Our latest news release for the trade media announces N4 Pharma’s research collaboration agreement with SRI, an independent non-for-profit research institute based in Silicon Valley, California, to combine Nuvec with SRI’s proprietary FOX Three Molecular Guidance System™ (MGS) to increase intercellular delivery to specific target cells. On the back of [...]